PTGX
Protagonist Therapeutics, IncCompany with tickers: PTGX
Market Cap
$7.86B
Shares Outstanding
64,311,373
CIK
1377121
CUSIP
74366E102
13F Activity (30d)
4 filings
3 filers
Website
Visit website
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Lewis T. "Rusty" Williams, M.D., Ph.D. | Class I director | Appointed | 2026-06-18 |
| Dinesh V. Patel, Ph.D. | Class I director | Appointed | 2026-06-18 |